These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10025759)

  • 21. Botulinum toxin in the treatment of blepharospasm and hemifacial spasm.
    Kenney C; Jankovic J
    J Neural Transm (Vienna); 2008; 115(4):585-91. PubMed ID: 17558461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Adverse effects associated with facial application of botulinum toxin: a systematic review with meta-analysis].
    Zagui RM; Matayoshi S; Moura FC
    Arq Bras Oftalmol; 2008; 71(6):894-901. PubMed ID: 19169530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety considerations in the use of botulinum toxins in children with cerebral palsy.
    Apkon SD; Cassidy D
    PM R; 2010 Apr; 2(4):282-4. PubMed ID: 20430330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Botulinum toxin useful against writer's cramp].
    Kruisdijk JJ; Koelman JH; Ongerboer de Visser BW; de Haan RJ; Speelman JD
    Ned Tijdschr Geneeskd; 2009 Jan; 153(4):118-23. PubMed ID: 19348131
    [No Abstract]   [Full Text] [Related]  

  • 25. Botulinum toxin treatment for blepharospasm associated with myasthenia gravis.
    Hara K; Matsuda A; Kitsukawa Y; Tanaka K; Nishizawa M; Tagawa A
    Mov Disord; 2007 Jul; 22(9):1363-4. PubMed ID: 17486596
    [No Abstract]   [Full Text] [Related]  

  • 26. Botulinum toxin as a treatment for blepharospasm, spasmodic torticollis and hemifacial spasm.
    Albanese A; Colosimo C; Carretta D; Dickmann A; Bentivoglio AR; Tonali P
    Eur Neurol; 1992; 32(2):112-7. PubMed ID: 1563461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations.
    Bhidayasiri R; Cardoso F; Truong DD
    Eur J Neurol; 2006 Feb; 13 Suppl 1():21-9. PubMed ID: 16417594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of facial spasm using botulinum toxin].
    Ruusuvaara P; Setälä K
    Duodecim; 1991; 107(19):1627-9. PubMed ID: 1365929
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment with botulinum toxin in neurologic pediatrics].
    Justus N; Lee SH; Berweck S; Heinen F
    Kinderkrankenschwester; 2007 Jul; 26(7):274-6. PubMed ID: 17726921
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of blepharospasm with botulinum toxin. A preliminary report.
    Frueh BR; Felt DP; Wojno TH; Musch DC
    Arch Ophthalmol; 1984 Oct; 102(10):1464-8. PubMed ID: 6385932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment with botulinum toxin in blepharospasm].
    Grandas F
    Arch Neurobiol (Madr); 1991; 54 Suppl 3():40-3. PubMed ID: 1810207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term treatment outcome with different formulations of botulinum toxin.
    Pérez-Saldaña MT; Tan EK; Burguera JA
    Eur J Neurol; 2009 Mar; 16(3):285-6. PubMed ID: 19364359
    [No Abstract]   [Full Text] [Related]  

  • 33. Contralateral weakness and fatigue after high-dose botulinum toxin injection for management of poststroke spasticity.
    Varghese-Kroll E; Elovic EP
    Am J Phys Med Rehabil; 2009 Jun; 88(6):495-9. PubMed ID: 19454855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum toxin for spastic GI disorders: a systematic review.
    Zhao X; Pasricha PJ
    Gastrointest Endosc; 2003 Feb; 57(2):219-35. PubMed ID: 12556788
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of facial spasm using botulinum toxin].
    Asanuma K; Kaji R
    No Shinkei Geka; 2003 May; 31(5):487-91. PubMed ID: 12755021
    [No Abstract]   [Full Text] [Related]  

  • 36. [The use of botulinum toxin in otorhinolaryngology--experiences and outlook].
    Laskawi R
    Laryngorhinootologie; 1997 Nov; 76(11):656-9. PubMed ID: 9517972
    [No Abstract]   [Full Text] [Related]  

  • 37. Botulinum toxin treatment of blepharospasm.
    Elston JS
    Adv Neurol; 1988; 50():579-81. PubMed ID: 3400511
    [No Abstract]   [Full Text] [Related]  

  • 38. Pilocarpine for the treatment of refractory dry mouth (xerostomia) associated with botulinum toxin type B.
    Dave SJ
    Am J Phys Med Rehabil; 2008 Aug; 87(8):684-6. PubMed ID: 18645325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum toxin: a deadly substance with great therapeutic effect.
    Holmes S
    Prof Nurse; 2003 Oct; 19(2):85-7. PubMed ID: 14593781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of blepharospasm and facial hemispasm by injection of botulinum toxin].
    Saraux H
    J Fr Ophtalmol; 1988; 11(3):237-40. PubMed ID: 3418019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.